Terumo (OTCMKTS:TRUMY) Shares Gap Up – Time to Buy?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped up before the market opened on Friday. The stock had previously closed at $13.2545, but opened at $14.53. Terumo shares last traded at $14.3720, with a volume of 761,457 shares.

Analyst Upgrades and Downgrades

Separately, Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, Terumo has an average rating of “Buy”.

Terumo Stock Up 8.1%

The business has a fifty day moving average of $15.13 and a 200 day moving average of $14.19. The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13. The firm has a market cap of $21.14 billion, a P/E ratio of 20.18 and a beta of 0.77.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.13. The firm had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Terumo had a return on equity of 10.44% and a net margin of 13.83%. On average, equities research analysts predict that Terumo Corp. will post 0.86 EPS for the current year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions.